AstraZeneca and Pfizer/BioNTech: Germany Faces Dilemma of What to do with Excess Vac
#1
AstraZeneca and Pfizer/BioNTech: Germany Faces Dilemma of What to do with Excess Vac

More and more vaccination centers and doctors offices are struggling to use their vaccine supplies before they expire. Now, federal authorities in Germany are desperately looking for storage options and exploring ways to donate doses abroad.


https://www.spiegel.de/international/ger...d9#ref=rss
Zitieren


Nachrichten in diesem Thema
AstraZeneca and Pfizer/BioNTech: Germany Faces Dilemma of What to do with Excess Vac - von Spiegel Online - 31.07.2021, 09:38

Gehe zu:


Benutzer, die gerade dieses Thema anschauen: 1 Gast/Gäste